Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells

Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy

(2018) Maryam Abtin et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Anticancer Properties of Phyto-Synthesized Silver Nanoparticles from Medicinal Plant Artemisia tschernieviana Besser Aerial Parts Extract Toward HT29 Human Colon Adenocarcinoma Cells

(2017) Hourie Khalili et al.   JOURNAL OF CLUSTER SCIENCE

Molecular genetics and cellular events of K-Ras-driven tumorigenesis

(2017) G G Jinesh et al.   ONCOGENE

Chromosomal Instability in Gastric Cancer Biology

(2017) Saffiyeh Saboor Maleki et al.   NEOPLASIA

RAS isoforms and mutations in cancer at a glance

(2016) G. Aaron Hobbs et al.   JOURNAL OF CELL SCIENCE

Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway

(2016) Ming Liu et al.   ONCOLOGY REPORTS

Epigenetic alterations in gastric cancer (Review)

(2015) DU-GUAN FU   Molecular Medicine Reports

Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line

(2015) CHUN-MEI YAN et al.   Molecular Medicine Reports

miR-200c inhibits breast cancer proliferation by targeting KRAS

(2015) Cailu Song et al.   Oncotarget

Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges

(2014) Sophie Laurent et al.   Expert Opinion on Drug Delivery

Effects of the Olive-Derived Polyphenol Oleuropein on Human Health

(2014) Barbara Barbaro et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cross Talk Between MicroRNA and Coding Cancer Genes

(2012) Tanja Kunej et al.   CANCER JOURNAL

Bovine Serum Albumin Bioconjugated Gold Nanoparticles: Synthesis, Hemolysis, and Cytotoxicity toward Cancer Cell Lines

(2012) Poonam Khullar et al.   Journal of Physical Chemistry C

Breast cancer and microRNAs: therapeutic impact

(2011) Marilena V. Iorio et al.   BREAST

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

(2010) Wendy De Roock et al.   LANCET ONCOLOGY

Mutant p53 Drives Invasion by Promoting Integrin Recycling

(2009) Patricia A.J. Muller et al.   CELL

Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy

(2009) David Z Chang et al.   Journal of Hematology & Oncology

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?

(2008) Sérgia Velho et al.   BMC CANCER